Promising HIV vaccine to be tested with gay men and trans people
This article is a helpful overview of Mosaico, a global HIV-prevention vaccine study enrolling 3,800 sexually active HIV-negative gay men and transgender people age 18-60.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.